Visual outcomes after surgery for primary rhegmatogenous retinal detachment in era of microincision vitrectomy: Japan-Retinal Detachment Registry Report IV
- PMID: 32245850
- DOI: 10.1136/bjophthalmol-2020-315945
Visual outcomes after surgery for primary rhegmatogenous retinal detachment in era of microincision vitrectomy: Japan-Retinal Detachment Registry Report IV
Abstract
Background/aim: To determine the preoperative ocular factors and surgical methods that led to best-corrected visual acuity (BCVA) after pars plana vitrectomy (PPV) or scleral buckling (SB) for rhegmatogenous retinal detachment (RRD).
Methods: This was a prospective, nationwide, multicentre, observational study. Data from the Japanese Retina and Vitreous Society registry from 2016 to 2017 were used to determine the association between preoperative clinical factors, surgical procedures and postoperative BCVA at 6 months. Japanese individuals >40 years of age were included. Eyes with proliferative vitreoretinopathy were included. The primary outcome was the percentage of eyes that achieved 20/25 vision.
Results: Of the 3219 registered cases, 2192 met the inclusion criteria (344 SB, 1738 PPV, 110 PPV+SB). Cases with preoperative BCVA (≤0 logarithm of the minimum angle of resolution (logMAR) units) had good postoperative BCVA (OR=3.97, CI 2.87 to 5.51). Older age (>70 years), low intraocular pressure (<10 mm Hg), high myopia (<-5 dioptres), multiple retinal breaks (>4), giant retinal tear (>90°), wide retinal detachment (>3 quadrants) and macula-off detachment were associated with less probability of postoperative 20/25 vision (OR=0.39, 0.64, 0.62, 0.60, 0.12, 0.51 and 0.36, respectively). Postoperative BCVA was 0.03±0.23 and 0.10±0.32 logMAR units after SB and PPV, respectively. The percentage of cases that achieved 20/25 vision was not significantly different after PPV or SB if cases that had concurrent cataract surgery were excluded (p=0.251).
Conclusions: Better BCVA in patients with RRD who had undergone PPV was observed. However, if concurrent cataract surgery is not performed, BCVA will be comparable with either PPV or SB.
Keywords: retina; treatment surgery; vision.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: TB reports personal fees from Bayer Yakuhin, personal fees from Kowa, personal fees from Santen, personal fees from Senju, grants and personal fees from Novartis Pharma KK, personal fees from Alcon Japan, outside the submitted work. RK reports personal fees and other from Topcon, grants and personal fees from Senju, grants and personal fees from Novartis Pharma KK, grants from Pfizer, grants and personal fees from Bayer Yakuhin, personal fees from Roche, personal fees from Takeda, personal fees from Kowa, personal fees from Novo Nordisk, personal fees from Astellas, personal fees from Santen, personal fees from Nitto Medic, personal fees from Office Future, personal fees from Predictive Analytics, personal fees from MICIN, outside the submitted work. KY reports personal fees from Bayer Yakuhin, personal fees from HOYA Corporation, personal fees from Novartis Pharma KK, personal fees from Alcon Japan, personal fees from RE Medical, outside the submitted work. TK reports personal fees from Santen, personal fees from Bayer Yakuhin, personal fees from Novartis Pharma KK, personal fees from HOYA Corporation, personal fees from Ellex, personal fees from Pfizer, personal fees from Kowa, personal fees from Senju, outside the submitted work. KN reports personal fees from Santen, personal fees from RE Medical, personal fees from Carl Zeiss, personal fees from Alcon Japan, personal fees from Novartis Pharma KK, personal fees from Kowa, personal fees from Johnson & Johnson, personal fees from Senju, personal fees from Sanwa Kagaku Kenkyusho, personal fees from HOYA Corporation, outside the submitted work. SY reports grants and personal fees from Santen, grants and personal fees from Jamecs, personal fees from HOYA Corporation, personal fees from Pfizer, personal fees from Senju, personal fees from Alcon Japan, personal fees from Nidek, personal fees from Kowa, personal fees from Bayer Yakuhin, outside the submitted work. TS reports personal fees from Bayer Yakuhin, personal fees from HOYA Corporation, personal fees from Novartis Pharma KK, personal fees from Alcon Japan, personal fees from RE Medical, personal fees from Santen, personal fees from Senju, outside the submitted work.
Similar articles
-
Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.BMC Ophthalmol. 2015 Dec 9;15:173. doi: 10.1186/s12886-015-0167-z. BMC Ophthalmol. 2015. PMID: 26645589 Free PMC article.
-
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study.Ophthalmology. 2007 Dec;114(12):2142-54. doi: 10.1016/j.ophtha.2007.09.013. Ophthalmology. 2007. PMID: 18054633 Clinical Trial.
-
Scleral buckling versus vitrectomy for young japanese patients with rhegmatogenous retinal detachment in the era of microincision surgery: real-world evidence from a multicentre study in Japan.Acta Ophthalmol. 2019 Aug;97(5):e736-e741. doi: 10.1111/aos.14050. Epub 2019 Feb 11. Acta Ophthalmol. 2019. PMID: 30741467
-
Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments.Cochrane Database Syst Rev. 2019 Mar 8;3(3):CD009562. doi: 10.1002/14651858.CD009562.pub2. Cochrane Database Syst Rev. 2019. PMID: 30848830 Free PMC article.
-
Scleral Buckling Alone or in Combination with Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment Repair: A Meta-Analysis of 7,212 Eyes.Ophthalmologica. 2022;245(4):296-314. doi: 10.1159/000524888. Epub 2022 May 9. Ophthalmologica. 2022. PMID: 35533652
Cited by
-
Effect of surgeon-related factors on outcome of retinal detachment surgery: analyses of data in Japan-retinal detachment registry.Sci Rep. 2022 Mar 10;12(1):4213. doi: 10.1038/s41598-022-07838-5. Sci Rep. 2022. PMID: 35273253 Free PMC article.
-
Shorter Axial Length Is a Risk Factor for Proliferative Vitreoretinopathy Grade C in Eyes Unmodified by Surgical Invasion.J Clin Med. 2021 Aug 31;10(17):3944. doi: 10.3390/jcm10173944. J Clin Med. 2021. PMID: 34501393 Free PMC article.
-
TMEM132D and VIPR2 Polymorphisms as Genetic Risk Loci for Retinal Detachment: A Genome-Wide Association Study and Polygenic Risk Score Analysis.Invest Ophthalmol Vis Sci. 2023 Sep 1;64(12):17. doi: 10.1167/iovs.64.12.17. Invest Ophthalmol Vis Sci. 2023. PMID: 37695605 Free PMC article.
-
Surgical Outcomes of Rhegmatogenous Retinal Detachment with Different Peripheral Vitreous-Shaving Procedures.Clin Ophthalmol. 2021 May 28;15:2197-2202. doi: 10.2147/OPTH.S310789. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34113072 Free PMC article.
-
Japan-epiretinal membrane (J-ERM) registry: A prospective cohort study protocol investigating the surgical outcome of epiretinal membrane.PLoS One. 2024 Feb 8;19(2):e0297347. doi: 10.1371/journal.pone.0297347. eCollection 2024. PLoS One. 2024. PMID: 38329968 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous